诱导铁死以改善癌症治疗:增强免疫治疗的有希望的工具
Matteo Caforio1, Stefano Iacovelli2, Franco Locatelli2,3
1Department of Onco-Hematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. matteo.caforio@opbg.net.
Journal of experimental & clinical cancer research : CR
|December 3, 2025
概括
铁亡诱导通过改善免疫反应和促进瘤细胞死亡来提高癌症免疫疗法的有效性. 与免疫检查点抑制剂或CAR T细胞疗法结合铁灭诱导剂显示出有前途的抗瘤活性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞死亡机制 细胞死亡机制
背景情况:
- 铁灭,一种新的细胞死亡机制,为癌症,特别是复发病例提供了新的治疗策略.
- 针对铁亡途径的化合物可以抑制或诱导癌细胞中这种细胞死亡机制.
研究的目的:
- 审查ferroptosis诱导剂在增强癌症免疫治疗中的作用.
- 探索铁灭症诱导与免疫检查点抑制剂和CAR T细胞治疗的结合.
主要方法:
- 关于铁灭症诱导剂及其对免疫细胞的影响的文献综述.
- 对结合铁致死诱导剂与免疫检查点抑制剂 (ICI) 和化学抗原受体 (CAR) T 细胞治疗的研究的分析.
主要成果:
- 铁灭诱导剂通过调节免疫系统的部分来提高免疫疗法的有效性,包括树突细胞,调节性T细胞,自然杀伤细胞和与瘤相关的巨细胞.
- 铁灭诱导剂的联合治疗与针对CTLA4,PD-1和PD-L1的ICI显示出有前途的结果.
- 将铁致死诱导剂与CAR T细胞疗法结合起来,通过增强瘤细胞死亡和免疫性,显示出显著的抗瘤活性,特别是在固体瘤中.
结论:
- 需要进行临床试验,以验证铁致死诱导与当前癌症疗法结合的疗效.
- 铁酶调节是一种有前途的治疗方法,在癌症治疗中具有很高的转化潜力.
更多相关视频
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Necrosis
6.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K


